GreenLight Biosciences Acquires Bayer's topical RNA Intellectual Property portfolio

Autor: PR Newswire
Zdroj: PR Newswire US. 05/20/2021.
Abstrakt: BOSTON, May 20, 2021 /PRNewswire/ -- GreenLight Biosciences today announced that they have acquired rights to portions of Bayer's topical RNA Intellectual Property portfolio. These assets include bee health capabilities to protect against Varroa mites, a major threat to honeybees. [ABSTRACT FROM PUBLISHER]
Databáze: Regional Business News
Nepřihlášeným uživatelům se plný text nezobrazuje